inhibit
extracellular
matrix
ecm
degrad
may
repres
mechan
cardiac
protect
ischemia
extracellular
matrix
metalloproteinas
induc
emmprin
highli
express
respons
acut
myocardi
infarct
ami
induc
activ
sever
matrix
metalloproteinas
mmp
includ
gelatinas
target
emmprin
paramagneticfluoresc
micellar
nanoparticl
conjug
emmprin
bind
peptid
scrambl
peptid
neg
control
napsc
found
bind
endogen
emmprin
cultur
myocyt
mous
heart
subject
ischemiareperfus
ir
inject
time
one
day
ir
enough
reduc
progress
myocardi
cell
death
compar
control
napsc
inject
mice
infarct
size
inject
mice
vs
control
napsc
inject
mice
way
cardiac
paramet
recov
almost
healthi
level
lvef
vs
control
napsc
wherea
ecm
degrad
also
reduc
shown
inhibit
activ
cardiac
magnet
reson
cmr
scan
shown
signal
enhanc
left
ventricl
inject
mice
respect
noninject
mice
inject
napsc
posit
correl
cmr
enhanc
evansbluettc
stain
infarct
size
calcul
taken
togeth
result
point
emmprin
target
nanoparticl
new
approach
mitig
ischemicreperfus
injuri
earli
coronari
arteri
reperfus
effect
procedur
treatment
acut
myocardi
infarct
ami
howev
reperfus
associ
damag
often
worsen
cardiac
integr
part
elicit
extens
inflammatori
respons
proinflammatori
macrophag
play
pivot
role
express
extens
amount
proinflammatori
cytokin
extracellular
matrix
metalloproteinas
mmp
thu
contribut
ventricular
injuri
mmp
proteolyt
degrad
enzym
cleav
sever
protein
includ
extracellular
matrix
compon
heart
mmp
activ
induc
cardiac
myocyt
necrosi
heart
failur
elicit
abnorm
ventricular
remodel
regard
extracellular
matrix
metalloproteinas
induc
emmprin
regul
express
sever
mmp
play
role
inflammatori
respons
ischemia
monocyt
cardiac
cell
other
shown
emmprin
ivyspr
intern
publish
highli
express
monocyt
cardiac
myocyt
respons
ami
promot
express
activ
sever
mmp
includ
hypothes
target
inhibit
emmprin
may
repres
new
mechan
cardiac
protect
prevent
ecm
degrad
myocyt
cell
death
therebi
preserv
heart
contractil
follow
ischem
reperfus
gener
cell
cultur
suppli
purchas
bd
bioscienc
spain
calf
serum
biowhittak
vervier
belgium
cell
culturegrad
gelatin
trypsin
antibiot
hematoxylineosin
trichrom
masson
stain
reagent
evan
blue
ttc
dye
sigma
spain
hrpconjug
antimous
secondari
antibodi
liquid
dab
substrat
dako
carpinteria
ca
fitcconjug
secondari
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
antiheavi
chain
cardiac
myosin
antibodi
abcam
abcam
uk
hrpconjug
antirabbit
secondari
antibodi
sigmaaldrich
amersham
ecl
detect
kit
ge
ge
healthcar
life
scienc
spain
centrifug
concentr
sartoriu
fischer
scientif
spain
cardiomyocyt
cell
line
kindli
donat
dr
antonio
bernad
wild
type
mice
purchas
charl
river
hous
anim
facil
isol
room
anim
procedur
approv
nation
research
ethic
committe
conform
eu
direct
recommend
regard
protect
anim
use
experiment
scientif
purpos
enact
spanish
law
ischemia
induc
coronari
arteri
ligat
twelveweekold
mice
intraperiton
anesthet
ketaminexylazin
mgkg
respect
intub
steel
tube
ventil
strokesmin
thorax
open
second
third
rib
widen
aid
mous
retractor
pericardium
open
lad
occlud
min
close
bifurc
use
silk
sutur
blanch
ventricl
provid
direct
evid
coronari
occlus
reperfus
perform
ligat
releas
procedur
chest
close
neg
pressur
restor
skin
sutur
control
mice
sham
includ
assay
procedur
perform
except
occlus
left
coronari
arteri
myocardi
infarct
size
determin
doubl
stain
evan
bluettc
dye
anim
anesthet
evan
blue
solut
inject
aorta
allow
uniform
distribut
dye
anim
sacrif
heart
frozen
slice
ring
section
perpendicular
lv
long
axi
incub
ttc
solut
minut
healthi
tissu
blue
area
risk
red
infarct
tissu
pale
white
area
subject
morphometr
analysi
use
motic
imag
plu
softwar
mous
heart
visual
echocardiographi
time
use
highfrequ
microultrasound
system
vevo
visualson
toronto
canada
mice
anesthet
isofluran
ga
result
heart
rate
approxim
beatsmin
anesthet
anim
place
integr
rail
system
mous
handl
tabl
provid
manufactur
allow
simultan
acquisit
temperatur
data
use
integr
heat
pad
electrocardiographi
lead
ii
throughout
experi
chest
mous
care
shave
warm
ultrasound
transmiss
gel
appli
ensur
optim
imag
qualiti
parastern
shortaxisview
imag
heart
record
use
rmv
scan
head
bmode
allow
mmode
record
posit
cursor
parastern
shortaxi
view
perpendicular
interventricular
septum
posterior
wall
left
ventricl
record
follow
paramet
determin
use
onsit
softwar
cardiac
packag
visual
sonic
leftventricl
enddiastol
diamet
leftventricl
enddiastol
volum
eject
fraction
shorten
fraction
histolog
immunohistochem
procedur
perform
previous
describ
brief
mous
heart
embed
paraffin
serial
section
apart
obtain
apex
mid
lad
coronari
arteri
immunohistochem
detect
emmprin
perform
incub
section
correspond
primari
secondari
antibodi
red
fluoresc
emit
napsc
detect
nm
wavelength
leica
tc
ii
confoc
microscop
red
green
intens
serial
section
slidessect
analyz
coloc
finder
plugin
nih
imag
softwar
effect
napsc
cell
viabil
determin
flow
cytometri
fac
scanner
becton
dickinson
use
propidium
iodid
rd
system
annexin
v
conjug
life
technolog
provid
manufactur
isol
protein
lysat
immunoblot
perform
describ
peptid
yklpghhhhyrp
peptid
hyjlpghrhpyhk
paramagnet
nanoparticl
prepar
lipid
film
hydrat
method
modif
describ
brief
film
prepar
rotari
evapor
gddtpabi
gddtpabsa
methoxi
polyethylen
glycol
rhodaminep
molar
ratio
dissolv
mixtur
chloroformmethanol
vv
lipid
film
hydrat
hepe
buffer
ph
mm
nacl
solut
rotat
hour
correspond
scrambl
peptid
modifi
ad
termin
cystein
residu
fig
bind
maleimid
moieti
molar
ratio
micel
peptid
uncoupl
peptid
separ
centrifug
concentr
kda
number
peptid
molecul
bound
per
micel
calcul
hlpc
estim
number
peptid
present
napsc
respect
physic
chemic
properti
includ
zetapotenti
nanoparticl
size
calcul
hydrat
diamet
dynam
laser
light
scatter
dsl
malvern
zetas
nanoparticl
morpholog
visual
transmiss
electron
microscopi
tem
longitudin
transvers
relax
calcul
longitudin
relax
evalu
use
invers
recoveri
sequenc
invers
time
transvers
relax
calcul
spinecho
imag
differ
echo
time
case
seri
imag
differ
weight
gener
valu
estim
slope
longitudin
transvers
relax
rate
vs
gddtpa
nanoparticl
peptid
label
fluorescein
isothiocyan
fitc
fluorotagconjug
kit
sigmaaldrich
accord
instruct
fitclabel
peptid
micel
use
examin
affin
endogen
emmprin
cardiac
myocyt
adher
cell
plate
microwel
plate
incub
differ
concentr
hour
bind
experi
perform
absenc
presenc
excess
nonlabel
peptid
competit
assay
specif
test
incub
specif
antiemmprin
antibodi
end
incub
cell
resuspend
pellet
fluoresc
measur
supernat
free
peptid
micel
pellet
peptid
micel
bound
endogen
emmprin
fraction
kd
valu
calcul
graphpad
prism
softwar
magnet
reson
imag
mri
experi
perform
bruker
biospec
bruker
biospin
ettlingen
germani
oper
tesla
equip
cm
gradient
system
capabl
reach
maxim
gradient
strength
mtm
anim
anesthet
mixtur
isofluran
oxygen
place
prone
posit
insid
cm
birdcag
coil
bruker
biospin
ettlingen
germani
imag
acquisit
gate
ecg
respir
signal
use
extern
monitor
gate
system
saii
new
york
usa
local
short
axi
imag
plane
two
four
chamber
imag
acquir
along
entir
heart
mous
imag
ecg
respirationg
gradient
echo
imag
use
cardiac
respiratori
trigger
gradient
echo
imag
select
plane
acquir
contrast
agent
inject
measur
inject
repeat
everi
minut
case
hour
inject
imag
plane
acquir
separ
paramet
experi
tr
ms
te
ms
flip
angl
nex
matrix
x
fov
x
cm
slth
mm
imag
analysi
vivo
mr
imag
signaltonois
ratio
snr
region
interest
roi
defin
snr
roi
roi
nois
roi
intens
either
left
ventricl
interest
snr
lv
surround
muscl
snr
nois
standard
deviat
sd
outsid
anim
normal
enhanc
ratio
left
ventricl
ner
lv
muscl
defin
snrsignal
nois
ratio
mean
signal
intensitysd
eight
mr
imag
match
preand
postcontrast
slice
mous
use
analysi
unless
otherwis
specifi
data
express
mean
sd
cell
cultur
experi
perform
triplic
condit
assay
duplic
replic
anim
experi
perform
triplic
number
anim
replic
specifi
text
whenev
comparison
made
common
control
signific
differ
test
analysi
varianc
follow
dunnett
modif
test
differ
consid
signific
p
error
bar
repres
sd
target
micel
gener
ad
cystein
residu
nterminu
emmprin
bind
peptid
link
maleimid
moieti
micel
control
micel
gener
ad
cystein
residu
scrambl
peptid
conjug
napsc
fig
b
c
physic
chemic
properti
micel
shown
fig
affin
peptid
micel
endogen
emmprin
calcul
myocyt
see
method
detail
show
predict
bind
affin
nm
k
nm
respect
way
nanoprob
cytotox
test
myocyt
cell
cultur
hour
incub
increas
amount
percentag
live
necrot
apoptot
cell
determin
flow
cytometri
fig
select
concentr
nm
maxim
nanoparticl
concentr
signific
effect
cell
viabil
fig
visual
confoc
microscopi
red
fig
coloc
micel
endogen
emmprin
fyct
green
fig
restrict
posit
cell
merg
coloc
yellow
fig
vivo
toxic
assay
healthi
mice
day
iv
administr
mgkg
measur
serum
level
aspart
transaminas
ast
alanin
transaminas
alt
marker
liver
perform
creatinin
indic
kidney
function
creatinin
kinasemb
indic
cardiac
necrosi
show
signific
sign
liver
kidney
heart
muscl
toxic
fig
addit
biodistribut
test
confoc
microscopi
heart
liver
kidney
pancrea
spleen
lung
bladder
mgkg
inject
mice
hour
ir
show
higher
uptak
heart
lung
mice
fig
left
may
level
present
lung
respond
signific
accumul
micel
trap
pulmonari
microvasculatur
nevertheless
aggreg
visual
rather
strong
coloc
endogen
emmprin
pulmonari
alveoli
detect
confoc
microscopi
fig
right
mice
subject
ir
inject
mgkg
napsc
salin
control
hour
ir
cardiac
paramet
evalu
cardiac
ultrasound
anim
sacrif
analysi
fig
uptak
detect
confoc
microscopi
heart
healthi
mice
mice
subject
ir
dosag
select
amount
visual
confoc
microscopi
lower
toxic
fig
express
endogen
emmprin
stimul
cardiac
cell
result
ir
expect
fig
control
lower
panel
napsc
coloc
endogen
emmprin
heart
napsc
lower
panel
yellow
confoc
microscopi
visual
napsc
emmprin
myocyt
cell
incub
hour
napsc
nanoprob
uptak
evalu
detect
rhodamin
napsc
red
endogen
emmprin
detect
green
antiemmprin
primari
antibodi
fitcconjug
secondari
antibodi
green
coloc
detect
merg
fluoresc
signal
merg
panel
yellow
scale
bar
n
triplic
uptak
maxim
heart
section
mice
subject
ir
compar
heart
healthi
mice
mice
subject
ir
inject
mgkg
napsc
fig
lower
panel
doubl
immunostain
heart
section
mice
subject
ir
rhodamin
antimhc
antibodi
rhodamin
antibodi
show
specif
uptak
cardiac
myocyt
infiltr
macrophag
fig
iv
inject
mgkg
mice
subject
ir
improv
heart
contractil
fig
lvef
vs
control
napsc
respect
reduc
cardiac
necrosi
fig
infarct
size
vs
control
napsc
compar
mice
inject
napsc
salin
control
condit
tabl
list
cardiac
paramet
collect
mmode
ultrasound
evalu
mice
previous
found
ir
induc
express
emmprin
mous
heart
lead
express
activ
differ
mmp
includ
gelatinas
b
respect
two
crucial
ecmdegrad
enzym
heart
tissu
respons
ischem
condit
illustr
contribut
surviv
cardiac
myocyt
analyz
level
indic
emmprin
activ
heart
found
mice
inject
mgkg
level
almost
reduc
found
healthi
anim
fig
c
taken
togeth
result
show
improv
heart
contractil
least
part
target
emmprin
thorough
peptid
sinc
empti
micel
fig
control
micel
micel
contain
scrambl
peptid
fig
napsc
micel
reduc
level
improv
heart
contractil
test
whether
could
theranost
effect
perform
cmr
scan
healthi
mice
mice
subject
ir
inject
mgkg
napsc
salin
control
fig
healthi
anim
neither
napsc
caus
enhanc
heart
hour
post
inject
fig
upper
panel
contrast
mice
ir
inject
caus
signific
enhanc
heart
compar
control
napsc
inject
anim
fig
right
graphic
represent
correspond
independ
experi
show
normal
enhanc
ratio
control
ir
napsc
ir
ir
mice
use
evalu
ex
vivo
cardiac
damag
evan
bluettc
stain
detect
posit
correl
uptak
detect
cmr
ex
vivo
measur
infarct
size
fig
p
effect
ir
studi
design
b
lvef
healthi
heart
heart
mice
subject
ir
inject
one
day
group
time
group
b
one
day
group
c
mgkg
napsc
salin
control
measur
hour
inject
see
schemat
represent
assay
micecondit
mean
sd
p
vs
p
vs
b
immunoblot
detect
heart
gadp
use
load
control
micegroup
p
vs
control
found
induc
cardiac
protect
mous
heart
subject
ir
determin
best
time
nanoprob
administr
mice
inject
napsc
day
ir
group
time
ischemia
group
b
day
ir
group
c
fig
ventricular
function
fig
express
fig
analyz
hour
procedur
cardioprotect
effect
maxim
mice
inject
time
ischemia
one
day
ir
respect
control
mice
mice
inject
mgkg
napsc
subject
ir
fig
c
contrast
administr
ischemia
non
signific
effect
lvef
fig
express
fig
mice
subject
ir
inject
hour
later
mgkg
napsc
cmr
scan
perform
differ
time
inject
fig
visual
within
first
minut
signal
enhanc
within
next
two
hour
post
inject
fig
taken
togeth
result
suggest
might
use
inhibit
quantifi
extens
myocardi
cell
death
onset
progress
ami
target
emmpin
vivo
extracellular
matrix
degrad
key
step
preced
cardiac
remodel
result
coronari
arteri
occlus
subsequ
ischemia
reperfus
current
studi
found
target
extracellular
matrix
metalloproteinas
induc
emmprin
paramagnet
fluoresc
micellar
nanoparticl
success
reduc
reperfus
damag
heart
subject
ami
likewis
extracellular
matrix
degrad
detect
express
matrix
metalloproteinas
notabl
reduc
mice
inject
compar
napsc
contain
ap
scrambl
peptid
cmr
scan
mice
subject
ir
reveal
signal
enhanc
inject
wherea
scan
mice
inject
nanoparticl
conjug
scrambl
peptid
napsc
show
differ
respect
control
mice
confoc
microscopi
detect
heart
confirm
result
addit
coloc
endogen
emmprin
posit
correl
infarct
size
cmr
signal
enhanc
also
identifi
may
suggest
futur
consider
given
technolog
fast
noninvas
detect
heart
perform
improv
human
subject
ami
target
emmprin
investig
therapeut
mechan
numer
patholog
includ
sever
type
cancer
kidney
liver
lung
pancreat
diseas
involv
emmprin
cardiovascular
diseas
also
evidenc
atherosclerosi
induct
emmprin
monocyt
proinflammatori
macrophag
play
pivot
role
foam
cell
plaqu
format
smooth
muscl
cell
prolifer
migrat
platelet
activ
significantli
contribut
plaqu
burden
well
heart
infiltr
monocyt
cardiac
myocyt
produc
larg
amount
emmprin
respons
ischemia
promot
mmpmediat
extracellular
matrix
degrad
cardiac
cell
death
regard
found
antibodymedi
emmprin
inhibit
reduc
infarct
size
murin
model
ir
paramagnet
micel
use
target
cell
molecul
onset
progress
sever
diseas
coupl
differ
molecul
target
desir
cell
type
enzym
bind
protein
recent
pathophysiolog
condit
like
apoptosi
angiogenesi
even
ischemia
target
emmprin
use
gadolinium
basedparamagnet
micel
contain
specif
emmprin
bind
peptid
noninvas
visual
emmprin
molecular
mri
use
antibodymedi
target
protein
success
evalu
anim
model
diseas
howev
immunolog
approach
effect
studi
human
therefor
translat
clinic
limit
reason
includ
immun
cross
reactiv
antibodymedi
side
effect
lack
desir
therapeut
improv
avoid
undesir
immun
reactiv
effici
altern
use
smaller
bind
molecul
target
interest
includ
specif
bind
peptid
knowledg
use
specif
emmprinbind
peptid
test
vitro
inhibit
emmprin
downstream
mmp
activ
cell
monocyt
cell
peripher
blood
monocyt
isol
patient
rheumatoid
arthriti
found
first
time
paramagnet
nanoparticl
conjug
peptid
bind
emmprin
detect
confoc
microscopi
vivo
molecular
cmr
addit
administr
reduc
downstream
express
heart
improv
cardiac
contract
compar
conjug
nanoparticl
nevertheless
futur
translat
bed
side
requir
addit
nanoparticl
formul
avoid
potenti
nanoparticlederiv
side
effect
close
correl
cmr
signal
enhanc
myocardi
infarct
calcul
inject
mice
subject
ir
howev
effect
administ
day
ir
wherea
upon
administr
time
one
day
ir
improv
lvef
reduc
express
may
explain
due
reduc
express
emmprin
healthi
heart
conclus
nanotherapi
shown
effect
improv
perform
heart
subject
ir
restor
function
paramet
prevent
mmpmediat
ecm
degrad
consequ
studi
speci
crucial
futur
test
human
